Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Lymphoma Myeloma Leuk. 2014 Feb;14(1):e7-e11. doi: 10.1016/j.clml.2013.07.101. Epub 2013 Oct 26.

Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era.

Author information

1
Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany.
2
Department of General Pathology, University Hospital of Tuebingen, Tuebingen, Germany.
3
Department of Internal Medicine V and National Center for Tumor Diseases, University Hospital of Heidelberg, Heidelberg, Germany.
4
Department of Hematology, Oncology, Immunology, Rheumatology and Pulmonology, University Hospital of Tuebingen, Tuebingen, Germany. Electronic address: katja.weisel@med.uni-tuebingen.de.

KEYWORDS:

B-cell clonality; EBV; High-dose mephalan; Secondary primary malignancy; Thalidomide

PMID:
24169269
DOI:
10.1016/j.clml.2013.07.101
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center